Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105030750B details novel cajanin analogues with anti-HCV and anti-HIV activity, offering scalable synthesis routes for pharmaceutical intermediate manufacturing.
Patent CN112194633B reveals a novel one-pot copper-catalyzed route for Apalutamide intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent-based purification technology for Cyclovimbuxine D ensures high purity and supply chain stability for global pharmaceutical intermediates manufacturing partners.
Patent CN103451242A details a high-yield microbial conversion for 1-alpha-hydroxyvitamin D. Discover cost-effective, scalable manufacturing solutions for active vitamin D intermediates.
Patent CN102250173B reveals advanced methylation process for clarithromycin intermediates offering improved solvent recovery and reduced environmental impact for reliable pharmaceutical intermediates supplier partnerships.
Patent CN112194558B details a robust 3-step synthesis for a key pharmaceutical intermediate, offering high purity, scalable yields, and cost-effective manufacturing solutions.
Advanced preparation method for Iopromide eliminating bis-amide impurities. Streamlined process offers cost reduction in pharmaceutical manufacturing and scalable production.
Novel one-pot method for Cefditoren pivoxil improves yield and purity. Reduces manufacturing costs and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN1827605A details a metal-free route to HIV drug precursors. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediate supply.
Novel synthesis of substituted biphenyls for cholesterol treatment. Optimized reduction and cyclization routes ensure high purity and scalable supply for global pharmaceutical partners.
Advanced resin-based purification process for pristinamycin offering higher yields and reduced solvent consumption. Ideal for pharmaceutical manufacturers seeking cost-effective supply.
Novel reductive amination route for Rivastigmine intermediate CN101016257A. Enhances yield and purity for API manufacturing supply chains.
Patent CN113804805B details a green, solvent-free method for synthesizing Pregabalin Impurity II. This breakthrough ensures reliable quality control standards and reduces manufacturing costs for pharmaceutical intermediates.
Discover the patented one-pot synthesis of 5'-chloronucleosides using PPh3 and hexachloroethane. A reliable pharmaceutical intermediates supplier offering high purity and cost-effective manufacturing solutions.
Patent CN1507441A discloses novel tricyclic hydroxamates with superior antitumor activity. Discover scalable synthesis routes for high-purity pharmaceutical intermediates.
Patent CN107746399B details a 6-step synthesis of flavanone B from cheap raw materials. Offers 30% total yield, scalable route for API intermediates.
Patent CN109503596A reveals Pd-catalyzed synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable supply chain reliability.
Patent CN101585763B reveals a high-yield synthesis route for fexofenadine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101585767B reveals a high-yield synthesis for 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropionate, eliminating meta-isomers and reducing environmental impact for reliable supply.
Patent CN101585782B reveals a high-yield synthesis for Fexofenadine intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.